GSK vs TDAY · P/E 13, $103.31B cap vs P/E 43, rev $1.08B
GlaxoSmithKline PLC ADR (GSK) versus USA TODAY Co., Inc. (TDAY) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
USA TODAY Co., Inc. (TDAY) is a publishing company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported TDAY revenue for 2026-06-30 was $1.08B. Net income was $29.0M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. TDAY currently screens at market cap $1.13B and trailing P/E 42.7.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. TDAY currently screens at market cap $1.13B and trailing P/E 42.7.
Not investment advice. Open the GSK and TDAY stock pages for the full models.
Not investment advice.